Jian-ya Lin
PharmD
Pharmacy Management Consultant
Brookfield, WI, US
Jian-ya Lin is a pharmacy management consultant working from the Milwaukee office of Milliman. She joined the firm in 2023.
Experience
Jian-ya’s experience includes over 10 years working with health plans and PBMs.
Prior to joining Milliman, Jian-ya worked in various clinical and account leadership positions within a PBM subsidiary of a large Blue plan. Her specialties include Medicare formulary management and strategy and EGWP RFPs, sales strategies, account retention, and implementation.
Publications and Presentations
- Co-author, Battle royale: Part D EGWPs vs RDS plans in the era of the Inflation Reduction Act. Millman White Paper, February 2024.
- Co-author, Potential IRA interactions with Medicare Part D Risk Adjustment: Calibration Data Timing Considerations. Milliman White Paper, November 2023.
Education
- PharmD, University of California, San Francisco
Publications
Read their latest work
Article
Prescribing a Part D formulary for the new IRA world
13 December 2024 - by Madeleine Cline, Justin Harris, Jian-ya Lin, Mark F. Gruenhaupt, RPh
Medicare Part D: We highlight the changes in plan incentives and key trends in 2025 formulary coverage, along with considerations for 2026.
Article
Battle royale: Part D EGWPs vs. RDS plans in the era of the Inflation Reduction Act
13 February 2024 - by Matthew Dickett, Jian-ya Lin, Todd Wanta
The Inflation Reduction Act redefines Medicare Part D, so we highlight key factors plan sponsors should consider when evaluating options for retiree benefits.
Article
Potential IRA interactions with Medicare Part D Risk Adjustment: Calibration Data Timing Considerations
07 November 2023 - by Michelle (Klein) Robb, Jian-ya Lin
Regarding the Inflation Reduction Act’s potential effects on the Medicare Part D risk adjustment, we offer additional thoughts on calibrating the 2025 model.